Etidronate
 OpenBabel02212023462D

 11 10  0  0  0  0  0  0  0  0999 V2000
    1.6500   -0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8250   -0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000   -0.8250    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.8250   -1.6500    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
    0.8250   -2.4750    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.6500   -1.6500    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000   -1.6500    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.8250    0.0000    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
    0.8250    0.8250    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.6500   -0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  2  3  1  0  0  0  0
  2  4  1  0  0  0  0
  2  8  1  0  0  0  0
  4  5  2  0  0  0  0
  4  6  1  0  0  0  0
  4  7  1  0  0  0  0
  8  9  2  0  0  0  0
  8 10  1  0  0  0  0
  8 11  1  0  0  0  0
M  END
>  <CdId>
257

>  <Mol Weight>
206.0282

>  <Formula>
C2H8O7P2

>  <ID>
T0308

>  <Name>
Etidronate

>  <Synonyms>
HEDPA;HEDP

>  <CAS>
2809-21-4

>  <Approved status>
FDA

>  <Disease>
Cancer

>  <Indication>
Cancer Metastases; Cancer Pain

>  <Pathways>
Microbiology&Virology; Others

>  <Target>
HBV antagonist; Others inhibitor

>  <Receptor>
HAP; PTPase S; V-type proton ATPase catalytic subunit

$$$$
